TY  - JOUR
AU  - Herrera-Espejo, Soraya
AU  - Del-Barrio-Tofiño, Ester
AU  - Cebrero-Cangueiro, Tania
AU  - Lopez-Causape, Carla
AU  - Alvarez-Marin, Rocio
AU  - Cisneros, Jose Miguel
AU  - Pachon, Jeronimo
AU  - Oliver, Antonio
AU  - Pachon-Ibañez, Maria Eugenia
PY  - 2022
DO  - 10.3390/antibiotics11091212
SN  - 2079-6382
UR  - http://hdl.handle.net/10668/20766
T2  - Antibiotics (Basel, Switzerland)
AB  - In the context of difficult-to-treat carbapenem-resistant Pseudomonas aeruginosa infections, we evaluated imipenem, meropenem, and doripenem combinations against eleven carbapenemase-producing P. aeruginosa isolates. According to the widespread global...
LA  - en
PB  - MDDPI AG
KW  - carbapenemase-producing Pseudomonas aeruginosa
KW  - doripenem
KW  - efficacy studies
KW  - imipenem
KW  - meropenem
KW  - murine sepsis model
KW  - Carbapenems
KW  - Doripenem
KW  - Meropenem
KW  - Imipenem
KW  - carbapenemase
KW  - Pseudomonas aeruginosa
KW  - Anti-Infective Agents
TI  - Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis.
TY  - research article
VL  - 11
ER  -